7/16 A second approach followed: prademagene zamikeracel (pz-cel), approved in April 2025.
This therapy uses genetically corrected skin grafts grown in the laboratory, then surgically applied to chronic wounds.
Two different strategies, same goal: molecular repair.
#PZCel #SkinGrafts
0
0
1
0